Literature DB >> 7521089

Studies on calcium oxalate monohydrate crystallization: influence of inhibitors.

F Grases1, M Kroupa, A Costa-Bauzá.   

Abstract

A simple model to study calcium oxalate monohydrate (COM) crystallization on different substrates is presented and the action of different potential inhibitors is evaluated and discussed. COM heterogeneous nucleation was assayed on solid surfaces as calcium phosphate, mixtures of mucin with calcium phosphate, and wax. In the presence of a non-protected non-renewed solid surface in contact with normal urine, COM crystal formation could be detected at short intervals (3 h). The most active heterogeneous nucleation capacity corresponded to calcium phosphate. In the presence of 10% mucin, owing to the renewal of the surface layer no COM crystal were detected on the pellet's surface. The study of citrate and pentosan polysulphate (a semisynthetic polysaccharide) on COM heterogeneous nucleation demonstrated some important inhibitory effects when concentration increased and time decreased. Maximum effects were selectively manifested on calcium phosphate surfaces. Only phytic acid at adequate concentration exhibited a total inhibitory capacity of COM formation, even during longer intervals (15 h).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7521089     DOI: 10.1007/bf00431547

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  10 in total

Review 1.  Urothelial injury and clotting cascade activation: common denominators in particulate adherence to urothelial surfaces.

Authors:  W A See; R D Williams
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

2.  Sodium urate accelerates precipitation of calcium oxalate in vitro.

Authors:  F L Coe; R L Lawton; R B Goldstein; V Tembe
Journal:  Proc Soc Exp Biol Med       Date:  1975-09

Review 3.  Physicochemical aspects of urolithiasis.

Authors:  B Finlayson
Journal:  Kidney Int       Date:  1978-05       Impact factor: 10.612

4.  Tamm-Horsfall mucoproteins promote calcium oxalate crystal formation in urine: quantitative studies.

Authors:  G A Rose; S Sulaiman
Journal:  J Urol       Date:  1982-01       Impact factor: 7.450

5.  Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium citrate administered over the short-, medium- and long-term medication of male stone patients.

Authors:  P O Schwille; U Herrmann; C Wolf; I Berger; R Meister
Journal:  Urol Res       Date:  1992

6.  Study of factors affecting calcium oxalate crystalline aggregation.

Authors:  F Grases; A Costa-Bauzá
Journal:  Br J Urol       Date:  1990-09

7.  Glycosaminoglycans, uric acid and calcium oxalate urolithiasis.

Authors:  F Grases; A Costa-Bauzá; J G March; L Masárová
Journal:  Urol Res       Date:  1991

8.  Fine structure of calcium oxalate monohydrate renal calculi.

Authors:  O Söhnel; F Grases
Journal:  Nephron       Date:  1993       Impact factor: 2.847

9.  Protective effects of heparin and other sulfated glycosaminoglycans on crystal adhesion to injured urothelium.

Authors:  W B Gill; K W Jones; K J Ruggiero
Journal:  J Urol       Date:  1982-01       Impact factor: 7.450

10.  Agglomeration of calcium oxalate monohydrate in synthetic urine.

Authors:  F Grases; L Masárová; O Söhnel; A Costa-Bauzá
Journal:  Br J Urol       Date:  1992-09
  10 in total
  5 in total

1.  A new procedure to evaluate the inhibitory capacity of calcium oxalate crystallization in whole urine.

Authors:  F Grases; L García-Ferragut; A Costa-Bauzá
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

2.  Potential thermodynamic and kinetic roles of phytate as an inhibitor of kidney stone formation: theoretical modelling and crystallization experiments.

Authors:  Saajidah Fakier; Allen Rodgers; Graham Jackson
Journal:  Urolithiasis       Date:  2019-02-14       Impact factor: 3.436

3.  Urinary glycosaminoglycan excretion in healthy and stone-forming children.

Authors:  F Harangi; Z Györke; B Melegh
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

4.  Urinary pH and renal lithiasis.

Authors:  F Grases; A Costa-Bauzá; I Gomila; M Ramis; A García-Raja; R M Prieto
Journal:  Urol Res       Date:  2011-05-19

Review 5.  Key Aspects of Myo-Inositol Hexaphosphate (Phytate) and Pathological Calcifications.

Authors:  Felix Grases; Antonia Costa-Bauza
Journal:  Molecules       Date:  2019-12-04       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.